In this study, we were able to determine the amount of mRNA of MMP-9 and TIMP-1 in the few residual tumour tissues that were available (n=3 for each group, i.e., RGZ-treated (4 weeks) or control mice). This evidence concerns the gene MMP9 and neoplasm.